Vavricka John

Vavricka John is listed in filings as Chief Commercial Officer at Atea Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Feb 3, 2026, including 8 public disclosures. Recent filings connect the profile to Atea Pharmaceuticals, Inc. (AVIR). The current snapshot covers public activity from Feb 4, 2025 to Feb 3, 2026. Reported amounts are shown as $506.8K to $406.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.